Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS appoints top academic
2010-05-13

 
Prof. Kwandiwe Kondlo


The University of the Free State (UFS) has acquired the services of a well-known political analyst, Prof. Kwandiwe Kondlo, as a Senior Professor in the university’s Centre for Africa Studies (CAS).

Prof. Kondlo, who worked for the Human Sciences Research Council (HSRC) prior to this permanent appointment, is an accomplished researcher and a well-heeled scholar in issues of transitional democracies, governance and social justice.

“I joined this university particularly because of its difficult history and what I have observed to be a sincere orientation to transform,” he said.

“I think that under the leadership of Prof. Jonathan Jansen (Rector and Vice-Chancellor of the UFS) and his team we are going to see a very interesting rebirth of the University of the Free State. And some of us who believe in ideas of reconciliation in negotiated democracies as part of nation formation actually feel we should throw the best we have into the transformation process and support this great guy.”

“I see my appointment as part of the excellence aspect of the transformation journey because the UFS, even though it does good work in certain areas, is not highly rated in terms of academic excellence and publications. That is why I was glad to be appointed to make a humble contribution,” he said.

“I think it is going to be useful to the UFS to have more people of high academic standing because the idea to improve scholarship is very central and of course shifts the focus to scholarly discourse. Let scholarly excellence reclaim the centre of the debate as the leadership deal with legacy issues and genuine transformation.”

“Let us see academics from this institution stand up to articulate key issues that are relevant to state formations and transformation in the country. Let us debate our role as academics in supporting the consolidation of our young democracy”

Prof. Kondlo sees his key role within the CAS as improving research output.

“In other words, I see myself as leading the way in the generation of journal articles, books and also national and international seminars,” he explained.

He said a lot of work still needed to be done, though, to profile the CAS nationally and on the continent as it was still a new initiative and thus relatively unknown.

“We will need to be very innovative in terms of research initiatives and identification of research associates in order to profile the work of the Centre,” he said.

“I think the UFS will claim its seat in the greater African academic family by virtue of the quality of its products. We do not want to re-invent the wheel; we want to come up with products that are unique and in that way help this university to claim its rightful position within the greater African academic family.”

Prof. Kondlo has also worked for, amongst others, the Department of Land Affairs, the National Prosecuting Authority and the South African Chamber of Commerce, as well as being involved with the Truth and Reconciliation Commission.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za  
13 May 2010
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept